Agoracom Blog Home

Archive for the ‘Spyder Cannabis Inc.’ Category

Spyder Cannabis $SPDR.ca Receives Approval on Development Permit for its Flagship #Cannabis Store in Calgary, Alberta $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 8:54 AM on Monday, July 22nd, 2019
Spdr logo large
  • Announced that it has received approval on their development permit for a flagship retail location in the heart of Calgary
  • Spyder has now been accepted by Alberta Health Services and will begin construction in the coming weeks.

Vaughan, Ontario–(July 22, 2019) – Spyder Cannabis Inc.TSXV : SPDR) (“Spyder“), an established Canadian cannabis and vape retail operator, is pleased to announce that it has received approval on their development permit for a flagship retail location in the heart of Calgary.

In July 2018, Spyder acquired a lease for an approximately 8,000 square feet location in Calgary, Alberta, which Spyder intends to operate both as its flagship retail location, and as a central distribution hub for its product offerings. Spyder had received a municipal development and building permit in late 2018, subject to receiving a variance from the Province of Alberta. Spyder has now been accepted by Alberta Health Services and will begin construction in the coming weeks.

“We have built our Spyder retail brand to provide a superior customer experience and have focused on locations with high foot traffic in urban centres and destinations” said Dan Pelchovitz, Spyder President and CEO. “This will give us plenty of room to present an engaging retail experience, rooted in a customer centric retail concept with unique design, warm features, complete with well trained and knowledgeable staff”

This location brings Spyder’s total retail to 6 locations across Ontario and Alberta. This number is expected to grow over the coming months as the Spyder is currently negotiating additional leases with the intention of submitting applications for retail licenses. Spyder is executing an aggressive expansion plan to create a significant retail brand in the Canadian and U.S. adult use market. It is committed to acquiring and developing prime North American retail locations and continuing to expand the reach of its brand.

About Spyder

Founded in 2014 Spyder is an established chain of three high-end vape stores, and two cannabis accessory stores, in Ontario, with locations in Woodbridge, Scarborough, Burlington, Pickering and Niagara Falls. The Spyder brand is defined by its high-quality proprietary line of e-juice, liquids and exclusive retail deals, dispensed in uniquely designed stores creating the optimal customer experience. Spyder is building off this leading retail, distribution and branding eCig and vapes company and is pursuing expansion into the legal cannabis and hemp derived market. Spyder has developed a scalable retail model with plans to create a significant footprint with targeted and disciplined retail distribution strategy focusing on Canadian retail and U.S. boutique retail and kiosks in high traffic peripheral areas.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:

For more information, please contact:

Spyder Cannabis Inc.
Dan Pelchovitz
President & Chief Executive Officer
Telephone: (905) 265-8273
Email: [email protected]

Bullseye Corporate
Crystal Quast
Bullseye Corporate
[email protected]

Cautionary Statements

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities laws (“forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur..

These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made. Any number of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/46417

Spyder #Cannabis $SPDR.ca Signs Supply Agreement For Premium #Hemp Products And Unveils Their New SPDR(R) Line $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 8:39 AM on Thursday, July 18th, 2019
Spdr logo large
  • Announced that it signed its first hemp agreement for the supply of full spectrum products to support Spyder’s debut of a hemp infused product line to be sold across the U.S. under its SPDR(R) brand
  • Spyder is expanding its chain of hemp-infused medical and lifestyle product shops with their new brand
  • Initial launch will feature four distinct hemp-derived products; Balms at 125mg and 500mg strength, tinctures at 300mg, 500mg and 1,000mg strength, soft gel capsules at 15mg strength and a pet line starting with tinctures at 300 mg strength

Vaughan, Ontario–(July 18, 2019) – Spyder Cannabis Inc. (TSXV: SPDR) (“Spyder“), an established cannabis and vape retail operator intending to become one of North America’s leading hemp-infused medical and lifestyle company, today announced that it signed its first hemp agreement for the supply of full spectrum products to support Spyder’s debut of a hemp infused product line to be sold across the U.S. under its SPDR(R) brand.

Spyder is expanding its chain of hemp-infused medical and lifestyle product shops with their new brand called SPDR (R). These boutique shops will stock Spyder’s SPDR (R) branded hemp infused products developed for an aging, health and wellness demographic. Spyder will offer a wide array of hemp-infused product offerings including; muscle balm, face oil, body lotion and bath salts, as well as hemp-infused tinctures, capsules and sprays. In addition, hemp is a natural source of CBD, the non-intoxicating component of cannabis that can be used for health and wellness purposes in jurisdictions where legally permitted.

The hemp industry is booming and has the potential to become a $22 billion business by 2022, according to cannabis-focused research firm Brightfield Group. “Spyder plans on executing an aggressive expansion plan to create a significant retail brand in the U.S. hemp market,” stated Daniel Pelchovitz, CEO and President of Spyder. “We are very pleased to partner with this producer which will provide the product formulation and packaging to help create a premium product line for consumers across the U.S.”

The initial launch will feature four distinct hemp-derived products; Balms at 125mg and 500mg strength, tinctures at 300mg, 500mg and 1,000mg strength, soft gel capsules at 15mg strength and a pet line starting with tinctures at 300 mg strength.

About Spyder Cannabis

Founded in 2014 Spyder is an established chain of three high-end vape stores, and two cannabis accessory stores, in Ontario, with locations in Woodbridge, Scarborough, Burlington, Pickering and Niagara Falls. The Spyder brand is defined by its high-quality proprietary line of e-juice, liquids and exclusive retail deals, dispensed in uniquely designed stores creating the optimal customer experience. Spyder is building off this leading retail, distribution and branding eCig and vapes company and is pursuing expansion into the legal cannabis and hemp derived market. Spyder has developed a scalable retail model with plans to create a significant footprint with targeted and disciplined retail distribution strategy focusing on Canadian retail and U.S. boutique retail and kiosks in high traffic peripheral areas.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:

For more information, please contact:

Spyder Cannabis Inc.
Dan Pelchovitz
President & Chief Executive Officer
Telephone: (905) 265-8273
Email: [email protected]

Bullseye Corporate
Crystal Quast
Bullseye Corporate
[email protected]

Cautionary Statements

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities laws (“forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur..

These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made. Any number of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/46346

Spyder #Cannabis $SPDR.ca – #CBD-based Functional Drinks Charm Health Conscious Consumers $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 4:29 PM on Tuesday, July 16th, 2019

SPONSOR: Spyder Cannabis Inc. (TSX-V: SPDR) An established chain of high-end vape stores in Ontario, Canada. The company has an aggressive expansion plan already in place that will focus on Canadian retail and US Hemp-Derived kiosks in high traffic areas. Click here for more info.

Spdr logo large
(TSX-V: SPDR)
————————

CBD-based Functional Drinks Charm Health Conscious Consumers

  • Cannabis-based concentrates, extracts, and edibles are becoming highly popular among consumers
  • Specifically, the edible and beverage marketplace is quickly gaining popularity due to the ease at which customers can use the products

NEW YORK, July 16, 2019 — Each year, more and more countries are moving towards approving cannabis use. In particular, medicinal cannabis is witnessing immense support as most of the countries looking to enter into the market space are more keen on the medical sector due to the therapeutic benefits associated with cannabis. However, several regions around the world have also either decriminalized or legalized the use of recreational cannabis in moderate amounts. For instance, Canada completely legalized adult-use cannabis in late 2018. On the other hand, countries such as Colombia and Spain have only decriminalized recreational use, allowing adults to possess up to a certain amount.

Moreover, the U.S. has given states the jurisdiction to legalize cannabis or keep the drug illicit. As a result, more than half the U.S. legalized cannabis for medical use, while a fifth of the nation, including the District of Columbia, allows for legal recreational usage. While the medical marketplace is much more globally prevalent, the recreational market is expected to overshadow the medical segment as the North American market continues to mature.

Additionally, as the recreational market continues to expand, consumers are also experiencing an influx of new products. Aside from traditional cannabis flower, consumers can now choose from a variety of products at dispensaries and retail stores. Now, cannabis-based concentrates, extracts, and edibles are becoming highly popular among consumers. Specifically, the edible and beverage marketplace is quickly gaining popularity due to the ease at which customers can use the products.

Furthermore, a large recreational user base exists for the edible and beverage market, and the industry is heavily being accelerated by the increasing demand for wellness products to treat a variety of health concerns. According to data compiled by Reports and Data, the global cannabis-based beverage market was valued at USD 1.57 Billion in 2018. By 2026, the market is expected to reach USD 5.04 Billion while exhibiting a CAGR of 15.4% during the forecast period.

The cannabis-infused edible and beverage market is expected to witness a strong increase in demand, particularly for beverages over the next several years. Canaccord Genuity analyst Bobby Burleson noted last year that beverages packed with CBD or THC ingredients can account for nearly 20% of the U.S. edible products markets by 2022, increasing from 6% in 2018. Burleson highlighted that the growing beverage industry is becoming an attractive investment opportunity for beer and soda makers and that data has shown that there is a direct correlation between alcohol and cannabis consumption.

A joint research conducted by the University of Connecticut, Georgia State University, and Universidad Del Pacifico discovered that counties located in medical marijuana states witnessed a 15% reduction in monthly alcohol sales. The conclusion of the study uncovered that cannabis and alcohol are both substitutes for one another, meaning that they share the same target audience. The study also indicates that as more countries move towards cannabis legalization, more users will be inclined to shift over to the cannabis market. The shift has even prompted alcohol producers to enter into the cannabis industry to maximize its consumer base reach.

While alcohol beverage producers may look towards developing THC beverages, soda producers are looking to leverage CBD for health and wellness beverages. Soda producers are specifically focusing on CBD because of the consumer shifts from sugary drinks to more functional options. Regardless of the market type, Canaccord expects both the THC and CBD-based beverage markets in the U.S. to experience growth, as by 2022, Canaccord expects the demand for CBD beverages to reach USD 260 Million, while THC beverages are projected to reach USD 34 Million. “Interest has spiked from the beer industry on mounting evidence of a substitution relationship between cannabis and alcohol, while large soda companies increasingly view CBD as a natural fit within their strategically important wellness offerings,” Burleson wrote.

Read More: https://www.prnewswire.com/news-releases/cbd-based-functional-drinks-charm-health-conscious-consumers-300885358.html

CLIENT FEATURE: Spyder Cannabis $SPDR.ca An Established Chain of High-End #Vape Stores With Aggressive Expansion Plans $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 2:11 PM on Monday, July 15th, 2019

WHY SPYDER CANNABIS?

  • Developed a scalable retail model with aggressive expansion plan to create a significant retail footprint and establishing strategic partners as a top priority
  • Targeted and disciplined retail distribution strategy focusing on high quality, high traffic peripheral areas
  • Focused strategy aimed at vertical, horizontal and geographic diversification with demonstrated operations expertise and proven retail roll-out
  • Opened two additional stores in July for a total of 5 locations

Retail Locations

The Lundys Lane Location, two other retail locations that Spyder operates in Burlington and Calgary and a location that it intends to open in Guelph, subject to negotiating satisfactory terms with the landlord, will all be converted into cannabis retail stores as part of the Company’s “Cannabis Turn-Key Strategy”.

Under phase one of the Turn-Key Strategy

  • Spyder intends to operate a number of retail locations that will, in contrast to a number of its competitors, generate revenue by operating as retailers of a variety of non-cannabis products.

Under phase two of the Turn-Key Strategy

  • Spyder will, subject to the receipt of cannabis retail licences from the Alcohol and Gaming Commission of Ontario and the Alberta Gaming, Liquor and Cannabis Commission, convert these retailers into cannabis stores at the earliest possible opportunity.
  • The Company believes this strategy will allow it to generate stable revenue streams during the interim period before the stores receive a retail cannabis licence, and will allow the Company to swiftly pivot into the sale of cannabis products once appropriate licences have been received.

The Opportunity

Established Product Portfolio

 Hemp-Derived Market Opportunity

Retail Layout

FULL DISCLOSURE: Spyder Cannabis is an advertising client of AGORA Internet Relations Corp.

Spyder #Cannabis $SPDR.ca Looks To Create Value For Investors With Its Unique Retail Strategy $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 9:48 PM on Wednesday, July 3rd, 2019
  • The cannabis retail market represents a massive opportunity and it is much less saturated when compared to the cannabis cultivation opportunity
  • The company, Spyder Cannabis (SPDR: TSX Venture) recently completed a go-public transaction and has been flying under the radar

By Anthony Varrell

During the last year, the amount of interest in the legal cannabis industry has significantly increased and most of this attention has been focused on North America. This is a trend that we have been excited about as it has benefited the companies that are levered to the burgeoning cannabis market.

Earlier this month, we came across a cannabis business that is focused on the North American cannabis retail opportunity. The cannabis retail market represents a massive opportunity and it is much less saturated when compared to the cannabis cultivation opportunity. The company, Spyder Cannabis (SPDR: TSX Venture) recently completed a go-public transaction and has been flying under the radar.

Spyder Cannabis is an emerging opportunity that is focused on expanding into legal cannabis and hemp industry. The company has developed a scalable retail model that includes an aggressive expansion plan that is focused on creating a significant retail footprint while being highly focused on securing strategic partners.

Spyder Cannabis will utilize a targeting retail distribution strategy and will focus on the cannabis retail opportunity in Canada and the US. The company plans to open retail outlets in high-traffic locations and we are favorable on this approach.

Spyder Cannabis: An Execution Story to be Watching

One of the reasons we are excited about Spyder Cannabis is due to the focus on the cannabis opportunity in the US and Canada. These two markets represent massive opportunities for the company and we are bullish on the growth prospects associated with these markets. Spyder Cannabis will be utilizing a specific strategy to capitalize on each market and we find this to be significant. There are massive differences between the Canadian and the US cannabis market which has made the opportunity for Spyder even more significant.

An attractive aspect of Spyder Cannabis’ expansion plan is related to its plans to partner with a variety of developers to sign lease agreements for prime real estate in close proximity to senior living, sporting venues and malls throughout the US. The company plans to initially focus on the opportunity in California, Florida, Michigan and New York, and we will monitor how the team is able to open new retail outlets and increase market share in the US.

When a company is looking to open a cannabis retail operation, there are countless factors that must be considered. We believe that Spyder Cannabis has the right approach to opening locations and will monitor how the team is able to execute on its expansion strategy. By targeting the aging, athletics and health and wellness community, the company should be able to de-risk its expansion plan and we find this to be significant aspect of the story

Spyder Cannabis is developing a proprietary product line of hemp-derived ointments, oils, capsules and topical creams for the aging, sports and health and wellness space. The products will be sold directly to consumers through both kiosks and retail stores throughout the US. We are favorable on the markets the company is focused on and the strategy to reach consumers. Over the next year, we expect the US market to be a major value driver to Spyder Cannabis and this is an opportunity that we will continue to monitor.

A US Cannabis Retail Expansion Story

When looking at Spyder Cannabis’ approach to capitalizing on the US cannabis market, the first thing to stand out are the states that the company is focused on. Currently, Spyder is executing on an expansion in California, Florida, Michigan, and New York. These are four of the most exciting markets in the US and we are favorable on the growth prospects associated with these markets.

Spyder Cannabis is focused on opening branded boutique retail stores and kiosks in burgeoning cannabis markets in the US. The company has been working tirelessly on this expansion and has been successfully increasing market share in the states that it has entered. Over the next year, we expect to see the company build upon its existing footprint and are favorable on the value that can be created through this expansion.

By 2020, Spyder Cannabis plans to open between 30 to 50 boutique retail stores and kiosks and has developed a cost-effective strategy in order to execute on this. The company is focused on opening locations that require a limited amount of capital expenditures that are in secondary and tertiary markets and located in high-traffics areas. Specifically, Spyder Cannabis plans to open stores that are located close to malls, retirement centers, and sporting events.

A Canadian Expansion Story

When it comes to the Canadian cannabis opportunity, Spyder Cannabis has been executing on a nationwide expansion and already has three operational Spyder Vape stores open in Ontario. Over the next year, the company plans to significant increase its reach in Canada and plans to open 20 retail locations in Ontario, 5 retail locations in Alberta, and 5 retail locations in British Columbia.

Currently, there are two additional Spyder Vape stores under construction in Ontario and we will monitor how the management team is able to execute on this expansion. The company has been granted a development permit for a retail location in Alberta and we are favorable on the growth prospects associated with this market.

When it comes to the cannabis retail opportunity in Ontario, Spyder Cannabis is strategically positioning itself throughout the province through the opening of Spyder Vape stores. Once the company has received the necessary permits, it plans to convert these outlets to cannabis retail locations and we are favorable on the strategy in place.

Alberta represents a different type opportunity when it comes to the cannabis retail market. Currently, there is a cannabis supply shortage and the province has put a hold on issuing retail licenses. This has caused a steep decline in the price of development permits and Spyder Cannabis has been focused on acquiring permits for high-traffic locations.

An Industry Leader in the Making

Spyder Cannabis wants to become the most recognizable brand of independent retail stores and kiosks throughout North America. The company is focused on offering best-in-class cannabis products and tailored retail experiences in order to attract consumers and we are favorable on this approach. Spyder Cannabis has strategic partnership with more than 30 premium cannabis vendors and offers an industry leading portfolio of cannabis products.

One of the reasons we are bullish on Spyder Cannabis is due to the way that the management has positioned the business. The company is led by an executive team that has a proven track record of success and that has positioned the business to capitalize on the North American cannabis market. We are favorable on the growth prospects associated with the planned expansion and will monitor how the company continues to expand across North America.

We are favorable on the strategic relationships that Spyder Cannabis has been able to secure and find this to be an attractive aspect of the story. From real estate partners to cannabis brand partners, the company has done a fantastic job at pooling together its relationships to support all facets of the business. Spyder Cannabis will be leveraging its contacts for increased brand awareness and cross-selling opportunities. We are favorable on this strategy when it comes to becoming a leading cannabis brand and will be monitoring how the team executes on this.

Spyder Cannabis is a company that has significant potential catalysts for growth and this is an opportunity that we are excited about. To learn more about the North American cannabis company, please reach out to [email protected].

Pursuant to an agreement between StoneBridge Partners LLC and Spyder Cannabis we have been hired for a period of 30 days beginning June 11, 2019 and ending July 11, 2019 to publicly disseminate information about (SPDR) including on the Website and other media including Facebook and Twitter. We are being paid $6,750 per month (SPDR) for or were paid “ZERO” shares of unrestricted or restricted common shares. We own zero (0) shares of (SPDR), which we purchased in the open market. We plan to sell the “ZERO” shares of (SPDR) that we hold during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (SPDR) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

Source: https://technical420.com/cannabis-article/spyder-cannabis-looks-to-create-value-for-investors-with-its-unique-retail-strategy/#

Spyder Cannabis $SPDR.ca Celebrates Canada Day Weekend with Launch of New #Hemp Energy Drink Line $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 7:39 AM on Wednesday, June 26th, 2019
Spdr logo large
  • Announced that, in celebration of Canada Day, it will launch its new Hemp Energy Drink line over the Canada Day long weekend, on June 29, across its existing Ontario locations, as well as its two brand new accessories stores in Niagara Falls and Pickering, set to open this weekend.
  • Samples will be available at all locations.

Vaughan, Ontario–(June 26, 2019) – Spyder Cannabis Inc. (TSXV: SPDR) (“Spyder Cannabis” or the “Company“) is excited to announce that, in celebration of Canada Day, it will launch its new Hemp Energy Drink line over the Canada Day long weekend, on June 29, across its existing Ontario locations, as well as its two brand new accessories stores in Niagara Falls and Pickering, set to open this weekend. Samples will be available at all locations.

As previously disclosed in the Company’s press release of June 18, 2019, Spyder Cannabis signed an exclusive agreement with Tetra Natural Health, a subsidiary of Tetra Bio-Pharma (TSXV: TBP) (OTCQB: TBPMF), to distribute the three flavors of its Hemp Energy Drink in cannabis accessory stores, vape stores, and kiosks in Canada and the United States.

“We are thrilled to launch a premium brand, the Hemp Energy Drink, to our customers this Canada Day long weekend, starting June 29th. This is a historic time for the Canadian hemp industry, and we are excited to be at the forefront of the retail and wholesale distribution of innovative new products. Our focus is on providing unique and distinctive quality hemp derived options, specially curated to meet the needs of all Canadians. We are looking forward to sharing our products throughout Canada,” stated Daniel Pelchovitz, CEO and President of Spyder.


Figure 1

To view an enhanced version of Figure 1, please visit:
https://orders.newsfilecorp.com/files/3742/45892_16ecf44fe4f8b8d6_003full.jpg

About Spyder

Founded in 2014 Spyder is an established chain of three high-end vape stores in Ontario, with stores located in Woodbridge, Scarborough and Burlington. The Spyder brand is defined by its high-quality proprietary line of e-juice, liquids and exclusive retail deals, dispensed in uniquely designed stores creating the optimal customer experience. Spyder is building off this leading retail, distribution and branding eCig and vapes company and expanding into the legal cannabis and hemp derived market. Spyder has developed a scalable retail model with aggressive expansion plan to create a significant retail footprint with targeted and disciplined retail distribution strategy focusing on Canadian retail and U.S. hemp kiosks in high traffic peripheral areas.

About Tetra Natural Health:

Tetra Natural Health Inc. is a subsidiary of Tetra Bio-Pharma Inc. that focuses on identification, development and marketing of hemp or cannabis-based natural health products, or cannabinoids-based products authorized for sale by Health Canada. For more information, visit: www.tetranaturalhealth.com.

About Tetra Bio-Pharma:

Tetra Bio-Pharma (TSXV: TBP) (OTCQB: TBPMF) a biopharmaceutical leader in cannabinoid-based drug discovery and development with a Health Canada approved and FDA reviewed clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. Tetra Bio-Pharma has subsidiaries engaged in the development of an advanced and growing pipeline of Bio Pharmaceuticals, Natural Health and Veterinary Products containing cannabis and other medicinal plant-based elements. With patients at the core of its mission, Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies. For more information visit: www.tetrabiopharma.com

Cautionary Statements

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities laws (“forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur.

These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made. Any number of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:

Spyder Cannabis Inc.
Dan Pelchovitz
President & Chief Executive Officer
Telephone: (905) 265-8273
Email: [email protected]

Bullseye Corporate
Crystal Quast
Bullseye Corporate
[email protected]

Tetra Natural Health
Richard Giguère, CEO
Tel.: (438) 899-7575 ext. 210
[email protected]

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/45892

Spyder Cannabis $SPDR Announces Plans to Enter US Hemp Derived Market Through Rollout of Boutique Retail and Kiosk Stores $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 8:41 AM on Thursday, June 20th, 2019
Spdr logo large

  • Phase 1 of US rollout plan includes store locations in 4 states; Stores will include SPDR branded products
  • Spyder has begun partnering with a variety of developers and realtors to sign lease agreements for prime real estate that is strategically located in high traffic areas of malls, and near senior living centres and sporting venues throughout the United States
  • “This move will represent the first phase in Spyder’s strategic plan to develop a robust, planned network of boutique retail stores and kiosks across the US focused on the specific health and wellness aging and athletics sectors,” said Dan Pelchovitz, President and CEO of Spyder

Vaughan, Ontario–(June 20, 2019) – Spyder Cannabis Inc. (TSXV: SPDR) (“Spyder“), an established Ontario retail operator, announces plans to enter the U.S. market through an initial roll out of hemp derived boutique retail and kiosk locations over the next 12-18 months.

Spyder has begun partnering with a variety of developers and realtors to sign lease agreements for prime real estate that is strategically located in high traffic areas of malls, and near senior living centres and sporting venues throughout the United States. Spyder intends to initially target Florida, California, New York and Michigan. These boutiques will stock Spyder’s SPDR (R) branded hemp derived, and infused products developed for an aging, health and wellness demographic. Spyder will offer a wide array of hemp product offerings including; hemp -infused muscle balm, face oil, body lotion and bath salts, as well as hemp tinctures, capsules and sprays.

“This move will represent the first phase in Spyder’s strategic plan to develop a robust, planned network of boutique retail stores and kiosks across the US focused on the specific health and wellness aging and athletics sectors,” said Dan Pelchovitz, President and CEO of Spyder Cannabis. “With an already well-established and successful retail model in Ontario, we have a strong blueprint for success that we are ready to replicate in the US.”

Additional updates and details on rollout plans to follow.

About Spyder

Founded in 2014 Spyder is an established chain of three high-end vape stores in Ontario, with stores located in Woodbridge, Scarborough and Burlington. The Spyder brand is defined by its high-quality proprietary line of e-juice, liquids and exclusive retail deals, dispensed in uniquely designed stores creating the optimal customer experience. Spyder is building off this leading retail, distribution and branding eCig and vapes company and expanding into the legal cannabis and hemp derived market. Spyder has developed a scalable retail model with aggressive expansion plan to create a significant retail footprint with targeted and disciplined retail distribution strategy focusing on Canadian retail and U.S. hemp kiosks in high traffic peripheral areas.

Cautionary Statements

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities laws (“forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. In particular, this news release contains forward looking statements regarding, without limitation: Spyder’s intention to sign lease agreements for prime real estate locations in the United States; the timing of Spyder’s planned U.S. roll-out, both initially and overall; Spyder’s proposed retail hemp operations in the United States, including its ability to secure retail locations; Spyder’s ability to build, own and operate retail stores; the branding, staffing and customer experience of retail stores and kiosks; product selection; and the growth of a retail business in the United States and Spyder’s anticipated market share thereof.

These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made. Any number of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements including, but not limited to: the ability of the parties to receive and maintain, in a timely manner, the required government, regulatory and other third party approvals required to participate in the hemp retail market in the United States; the availability of appropriate retail locations in the identified areas; the timing and opening of retail locations; the assets and employees of Spyder; the availability of retail hemp products; changes to hemp laws; and changes in general market conditions.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:

For more information, please contact:

Spyder Cannabis Inc.
Dan Pelchovitz
President & Chief Executive Officer
Telephone: (905) 265-8273
Email: [email protected]

Bullseye Corporate
Crystal Quast
Bullseye Corporate
[email protected]

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/45747

AGORACOM Welcome’s Spyder #Cannabis $SPDR.ca An Established Chain of High-End Vape Stores in Ontario $META $N $NXTTF $WEED

Posted by AGORACOM-JC at 9:23 AM on Tuesday, June 18th, 2019

WHY SPYDER CANNABIS?

  • Developed a scalable retail model with aggressive expansion plan to create a significant retail footprint and establishing strategic partners as a top priority
  • Targeted and disciplined retail distribution strategy focusing on high quality, high traffic peripheral areas
  • Focused strategy aimed at vertical, horizontal and geographic diversification with demonstrated operations expertise and proven retail roll-out
  • Announced opening two additional retail stores within the next month for a total of 5 locations

Retail Locations

Spyder will open the new retail locations in the next month located in Niagara Falls at 6474 Lundys Lane and in Pickering at 776 Liverpool Road, Unit 4. The New Retail Locations will, initially, focus on the sale of cannabis accessories, hemp seed oil products, and hemp accessories.

The Lundys Lane Location, two other retail locations that Spyder operates in Burlington and Calgary and a location that it intends to open in Guelph, subject to negotiating satisfactory terms with the landlord, will all be converted into cannabis retail stores as part of the Company’s “Cannabis Turn-Key Strategy”.

Under phase one of the Turn-Key Strategy

  • Spyder intends to operate a number of retail locations that will, in contrast to a number of its competitors, generate revenue by operating as retailers of a variety of non-cannabis products.

Under phase two of the Turn-Key Strategy

  • Spyder will, subject to the receipt of cannabis retail licences from the Alcohol and Gaming Commission of Ontario and the Alberta Gaming, Liquor and Cannabis Commission, convert these retailers into cannabis stores at the earliest possible opportunity.
  • The Company believes this strategy will allow it to generate stable revenue streams during the interim period before the stores receive a retail cannabis licence, and will allow the Company to swiftly pivot into the sale of cannabis products once appropriate licences have been received.

Planned Expansion Across 3 Provinces

The Opportunity

Established Product Portfolio

 Hemp-Derived Market Opportunity

Retail Layout

New #Hemp Energy Drink to be offered to consumers in #cannabis accessory stores, #vapes stores, and kiosks in Canada and the US #Spyder $SPDR.ca $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 8:28 AM on Tuesday, June 18th, 2019
Spdr logo large
  • Tetra Natural Health, a subsidiary of Tetra Bio-Pharma (TSX VENTURE: TBP) (OTCQB: TBPMF), today announced that it has signed an exclusive agreement with Spyder Cannabis Inc. (TSX VENTURE: SPDR) to distribute the three flavors of its Hemp Energy Drink in cannabis accessory stores and vapes stores in Canada and the US
  • Drink is expected to be available to consumers in Spyder’s retail stores located in Scarborough, Woodbridge, Burlington, and shortly at the Niagara Falls and Pickering locations, which are expected to be opened early this summer.

OTTAWA, June 18, 2019 — Tetra Natural Health, a subsidiary of Tetra Bio-Pharma (TSX VENTURE: TBP) (OTCQB: TBPMF), today announced that it has signed an exclusive agreement with Spyder Cannabis Inc. (TSX VENTURE: SPDR) (“Spyder”) to distribute the three flavors of its Hemp Energy Drink in cannabis accessory stores and vapes stores in Canada and the US. The drink is expected to be available to consumers in Spyder’s retail stores located in Scarborough, Woodbridge, Burlington, and shortly at the Niagara Falls and Pickering locations, which are expected to be opened early this summer. A launch event will be held during the Canada Day long weekend at the Niagara Falls location situated at 6474 Lundys Lane.

“We are very excited to be adding the Hemp Energy Drink to our portfolio of premium brands that will be available to our growing clientele,” stated Daniel Pelchovitz, CEO and President of Spyder. “This new offering will please our customers who are always seeking unique and distinctive quality products in this emerging industry.” 

“This exclusive agreement allows us to take another step in implementing our distribution strategy and achieving our goal of making our Hemp Energy Drink accessible to all consumers â€œ said Richard Giguère, CEO of Tetra Natural Health “Consumers appreciate the qualities of the Hemp Energy Drink (HED) including the fact that it contains more natural ingredients than other energy drinks, and is the first energy drink made with hemp available in the country” adds Derek Theriault, National Sales Director of Tetra Natural Health.

About Tetra Natural Health:
Tetra Natural Health Inc. is a subsidiary of Tetra Bio-Pharma Inc. that focuses on identification, development and marketing of hemp or cannabis-based natural health products, or cannabinoids-based products authorized for sale by Health Canada. For more information, visit: www.tetranaturalhealth.com

About Spyder Cannabis Inc.
Founded in 2014 Spyder is an established chain of three high-end vape stores in Ontario, with stores located in Woodbridge, Scarborough and Burlington. The Spyder brand is defined by its high-quality proprietary line of e-juice, liquids and exclusive retail deals, dispensed in uniquely designed stores creating the optimal customer experience. Spyder is building off this leading retail, distribution and branding eCig and vapes company and is pursuing expansion into the legal cannabis market. Spyder has developed a scalable retail model with an aggressive expansion plan to create a significant retail footprint with targeted and disciplined retail distribution strategy focusing on Canadian locations in high traffic peripheral areas.

About Tetra Bio-Pharma:
Tetra Bio-Pharma (TSX-V: TBP) (OTCQB: TBPMF) a biopharmaceutical leader in cannabinoid-based drug discovery and development with a Health Canada approved and FDA reviewed clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. Tetra Bio-Pharma has subsidiaries engaged in the development of an advanced and growing pipeline of Bio Pharmaceuticals, Natural Health and Veterinary Products containing cannabis and other medicinal plant-based elements. With patients at the core of its mission, Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies. For more information visit: www.tetrabiopharma.com

Source: Tetra Bio-Pharma

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, the success of the Company’s research and development strategies, the applicability of the discoveries made therein, the successful and timely completion and uncertainties related to the regulatory process, the timing of clinical trials, the timing and outcomes of regulatory or intellectual property decisions and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. While no definitive documentation has yet been signed by the parties and there is no certainty that such documentation will be signed The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.


More information at: www.tetrabiopharma.com

For more information, please contact:
Tetra Natural Health
Richard Giguère, CEO
Tel.: (348) 899-7575 ext. 210
[email protected]

Spyder Cannabis Inc.
Dan Pelchovitz, President and CEO
Tel: (905) 265-8273
[email protected]


For TBP investors information, please contact:
[email protected]
(438) 504-5784

Media Contacts – Tetra Natural Health
Daniel Granger
ACJ Communication
W. 514 840-7990
M. 514 232-1556
[email protected]

Charlotte Blanche
W. 514 840-1235, ext. 7772
M. 514 914-0593
[email protected]


A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/267699bb-2f70-4744-8ecf-26cf47464a9c

Hemp Energy Drink (3 flavors)

Hemp Energy Drink (classic, mango and raspberry)

Source: GlobeNewswire (June 18, 2019 – 8:00 AM EDT)

News by QuoteMedia
www.quotemedia.com

Spyder Cannabis $SPDR.ca Announces Upcoming Opening of Additional Retail Locations and Launch of SPDR Website $META $N $NXTTF $WEED

Posted by AGORACOM-JC at 9:12 AM on Tuesday, June 11th, 2019
Spyder
  • Will be opening an additional two retail stores within the next month, for a total of 5 locations, and the upcoming launch of its proprietary SPDR website
  • Commences trading today on the TSX Venture Exchange,
  • Under phase one of the Turn-Key Strategy, Spyder intends to operate a number of retail locations that will, in contrast to a number of its competitors, generate revenue by operating as retailers of a variety of non-cannabis products
  • Under phase two of the Turn-Key Strategy, Spyder will, subject to the receipt of cannabis retail licences from the Alcohol and Gaming Commission of Ontario and the Alberta Gaming, Liquor and Cannabis Commission, convert these retailers into cannabis stores at the earliest possible opportunity

Vaughan, Ontario–(June 11, 2019) – Spyder Cannabis Inc. (TSXV: SPDR) (“Spyder” or the “Company“), an established Ontario retail operator, is pleased to announce that it will be opening an additional two retail stores within the next month (the “New Retail Locations“), for a total of 5 locations, and the upcoming launch of its proprietary SPDR website (the “SPDR Website“). The Company, which commences trading today on the TSX Venture Exchange, believes that the Retail Locations and the SDPR Website are a valuable part of its North American retail and e-commerce wellness growth strategy.

Retail Locations

The Company will open the New Retail Locations within the next month, which will be located in Niagara Falls at 6474 Lundys Lane (the “Lundys Lane Location“) and in Pickering at 776 Liverpool Road, Unit 4. The New Retail Locations will, initially, focus on the sale of cannabis accessories, hemp seed oil products, and hemp accessories.

The Lundys Lane Location, two other retail locations that Spyder operates in Burlington and Calgary and a location that it intends to open in Guelph, subject to negotiating satisfactory terms with the landlord, will all be converted into cannabis retail stores as part of the Company’s “Cannabis Turn-Key Strategy” (the “Turn-Key Strategy“). Under phase one of the Turn-Key Strategy, Spyder intends to operate a number of retail locations that will, in contrast to a number of its competitors, generate revenue by operating as retailers of a variety of non-cannabis products. Under phase two of the Turn-Key Strategy, Spyder will, subject to the receipt of cannabis retail licences from the Alcohol and Gaming Commission of Ontario and the Alberta Gaming, Liquor and Cannabis Commission, convert these retailers into cannabis stores at the earliest possible opportunity. The Company believes this strategy will allow it to generate stable revenue streams during the interim period before the stores receive a retail cannabis licence, and will allow the Company to swiftly pivot into the sale of cannabis products once appropriate licences have been received.

SPDR Website

The Company expects to launch the SPDR Website by July 1, 2019. The SPDR Website is currently in an advanced stage of development, and will focus on selling cannabis accessories and a variety of hemp-based products on a retail and wholesale basis within Canada. The Company intends to focus on offering its own SPDRTM branded products, which are made up of a number top-of-the line and unique products, along with leveraging the Company’s deep knowledge of the retail industry to offer a number of other best-in-class products that it has identified over the years.

“Spyder is excited to be able to announce our pending opening of two additional retail locations within Ontario, bringing our total to 5 operating stores and the launch of the SPDR website, which we believe demonstrate our commitment to creating value for our shareholders, a responsibility we take seriously as a newly listed company. We recently promised that we would take tangible steps to benefit our shareholders, and we believe that these latest developments leave us headed in the right direction,” said Dan Pelchovitz, Chief Executive Officer and President of Spyder.

About Spyder

Founded in 2014 Spyder is an established chain of three high-end vape stores in Ontario, with stores located in Woodbridge, Scarborough and Burlington. The Spyder brand is defined by its high-quality proprietary line of e-juice, liquids and exclusive retail deals, dispensed in uniquely designed stores creating the optimal customer experience. Spyder is building off this leading retail, distribution and branding eCig and vapes company and is pursuing expansion into the legal cannabis market. Spyder has developed a scalable retail model with aggressive expansion plan to create a significant retail footprint with targeted and disciplined retail distribution strategy focusing on Canadian locations in high traffic peripheral areas.

Cautionary Statements

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities laws (“forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. In particular, this news release contains forward looking statements regarding, without limitation: Spyder’s anticipated roll-out of the New Retail Locations and the SPDR Website in the timelines indicated or at all, the receipt by Spyder of cannabis licences on the timelines indicated or at all, and the products that Spyder plans to offer at the New Retail Locations and the SPDR Website.